KZA 15.6% 44.5¢ kazia therapeutics limited

*** alert: asco meeting in 2 weeks ***

  1. 3,567 Posts.
    Yale university is presenting Phase II trial results for Novogen's Phenoxodiol at the 30 May ASCO conference.

    This is a massive conference that is attended by journos, large Pharma's, doctors, patients, investors, analysts etc etc. I believe it's the most important conference in the year for cancer drugs.

    We Know already that Phenoxodiol has worked to some degree in this trial. Dr Rutherford stated that they have seen cancer regression and stabilisation in a number of patients. It pays to note that Novogen is an unknown stock in America. It's no Amgen or Imclone. But when people get wind of the story then we'll see all hell break loose.

    I'm expecting Novogen to become a market darling... currently it's an ugly duckling. Have a guess what the share price will do.

    You have been alerted.


    I own some NRT shares.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist
(20min delay)
Mkt cap ! $32.11M
Open High Low Value Volume
40.0¢ 45.0¢ 39.0¢ $53.88K 134.6K

Buyers (Bids)

No. Vol. Price($)
1 6000 41.0¢

Sellers (Offers)

Price($) Vol. No.
44.5¢ 29033 1
View Market Depth
Last trade - 15.57pm 03/04/2020 (20 minute delay) ?
KZA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.